Cancer, Heterogeneity, Instability and Plasticity (CHIP) France

Research

Date range: 1 October 2020 - 30 September 2021

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Cancer, Heterogeneity, Instability and Plasticity (CHIP) published between 1 October 2020 - 30 September 2021 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Cancer, Heterogeneity, Instability and Plasticity (CHIP)
Count Share
10 1.02

Outputs by subject (Share)

Outputs by subject
Subject Count Share
10 1.02
1 0.01

Share output for the past 5 years

Share per year
2016 2017 2018 2019 2020
0.00 0.00 0.00 0.00 0.08

Compare Cancer, Heterogeneity, Instability and Plasticity (CHIP) with other institutions

Collaboration

Date range: 1 October 2020 - 30 September 2021

International vs. domestic collaboration by Share

  • 76.26% Domestic
  • 23.74% International

Hover over the graph to view the percentage of collaboration.


Top 10 domestic collaborators with Cancer, Heterogeneity, Instability and Plasticity (CHIP) by Share (61 total)

  1. Cancer, Heterogeneity, Instability and Plasticity (CHIP) and Curie Institute (2.75)
    Cancer, Heterogeneity, Instability and Plasticity (CHIP)1.02
    Curie Institute1.74
  2. Cancer, Heterogeneity, Instability and Plasticity (CHIP) and National Institute for Health and Medical Research (INSERM) (2.49)
    Cancer, Heterogeneity, Instability and Plasticity (CHIP)1.02
    National Institute for Health and Medical Research (INSERM)1.47
  3. Cancer, Heterogeneity, Instability and Plasticity (CHIP) and French National Centre for Scientific Research (CNRS) (1.28)
    Cancer, Heterogeneity, Instability and Plasticity (CHIP)0.75
    French National Centre for Scientific Research (CNRS)0.53
  4. Cancer, Heterogeneity, Instability and Plasticity (CHIP) and University of Paris (1.17)
    Cancer, Heterogeneity, Instability and Plasticity (CHIP)0.75
    University of Paris0.42
  5. Cancer, Heterogeneity, Instability and Plasticity (CHIP) and Ligue Contre Le Cancer (1.10)
    Cancer, Heterogeneity, Instability and Plasticity (CHIP)0.71
    Ligue Contre Le Cancer0.38
  6. Cancer, Heterogeneity, Instability and Plasticity (CHIP) and Sorbonne University (0.86)
    Cancer, Heterogeneity, Instability and Plasticity (CHIP)0.64
    Sorbonne University0.22
  7. Cancer, Heterogeneity, Instability and Plasticity (CHIP) and Assistance Publique-Hôpitaux de Paris (AP-HP) (0.79)
    Cancer, Heterogeneity, Instability and Plasticity (CHIP)0.70
    Assistance Publique-Hôpitaux de Paris (AP-HP)0.09
  8. Cancer, Heterogeneity, Instability and Plasticity (CHIP) and ICGex (0.72)
    Cancer, Heterogeneity, Instability and Plasticity (CHIP)0.51
    ICGex0.21
  9. Cancer, Heterogeneity, Instability and Plasticity (CHIP) and Federative Research Structure "Biology: from basics to Medicine" (TransBioMed) (0.63)
    Cancer, Heterogeneity, Instability and Plasticity (CHIP)0.07
    Federative Research Structure "Biology: from basics to Medicine" (TransBioMed)0.56
  10. Cancer, Heterogeneity, Instability and Plasticity (CHIP) and Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC) (0.60)
    Cancer, Heterogeneity, Instability and Plasticity (CHIP)0.03
    Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC)0.58

Top 10 international collaborators with Cancer, Heterogeneity, Instability and Plasticity (CHIP) by Share (81 total)

  1. Cancer, Heterogeneity, Instability and Plasticity (CHIP) and National Institutes of Health (NIH) (0.79)
    Cancer, Heterogeneity, Instability and Plasticity (CHIP)0.03
    National Institutes of Health (NIH)0.76
  2. Cancer, Heterogeneity, Instability and Plasticity (CHIP) and The University of Manchester (UoM) (0.42)
    Cancer, Heterogeneity, Instability and Plasticity (CHIP)0.08
    The University of Manchester (UoM)0.33
  3. Cancer, Heterogeneity, Instability and Plasticity (CHIP) and University of Birmingham (UB) (0.35)
    Cancer, Heterogeneity, Instability and Plasticity (CHIP)0.10
    University of Birmingham (UB)0.25
  4. Cancer, Heterogeneity, Instability and Plasticity (CHIP) and University of Toronto (U of T) (0.33)
    Cancer, Heterogeneity, Instability and Plasticity (CHIP)0.01
    University of Toronto (U of T)0.32
  5. Cancer, Heterogeneity, Instability and Plasticity (CHIP) and St. Anna Children's Hospital (0.33)
    Cancer, Heterogeneity, Instability and Plasticity (CHIP)0.05
    St. Anna Children's Hospital0.28
  6. Cancer, Heterogeneity, Instability and Plasticity (CHIP) and Memorial Sloan Kettering Cancer Center (MSKCC) (0.24)
    Cancer, Heterogeneity, Instability and Plasticity (CHIP)0.11
    Memorial Sloan Kettering Cancer Center (MSKCC)0.13
  7. Cancer, Heterogeneity, Instability and Plasticity (CHIP) and King's College London (KCL) (0.23)
    Cancer, Heterogeneity, Instability and Plasticity (CHIP)0.10
    King's College London (KCL)0.13
  8. Cancer, Heterogeneity, Instability and Plasticity (CHIP) and University of Copenhagen (UCPH) (0.17)
    Cancer, Heterogeneity, Instability and Plasticity (CHIP)0.08
    University of Copenhagen (UCPH)0.08
  9. Cancer, Heterogeneity, Instability and Plasticity (CHIP) and Rigshospitalet (0.17)
    Cancer, Heterogeneity, Instability and Plasticity (CHIP)0.08
    Rigshospitalet0.08
  10. Cancer, Heterogeneity, Instability and Plasticity (CHIP) and University of Erlangen-Nuremberg (FAU) (0.16)
    Cancer, Heterogeneity, Instability and Plasticity (CHIP)0.05
    University of Erlangen-Nuremberg (FAU)0.11